Table 1 FolATED Baseline and follow-up assessments
Assessment | Outcome measure | Respondent | Trial entry – Baseline | Follow-ups | ||||
|---|---|---|---|---|---|---|---|---|
Week -2 (baseline 1) | Week -1 (Telephone contact) | Week 0 (baseline 2) | Week 4 | Week 12 | Month 6 | |||
Blood testing | Routine haematology | |||||||
FBC | Clinician |
| ||||||
Serum folate | Clinician |
|
|
| ||||
Red Cell folate | Clinician |
| ||||||
B12 | Clinician |
|
|
| ||||
Homocysteine | Clinician |
|
|
| ||||
Genetics | Clinician |
| ||||||
Depression status | BDI | Patient |
|
|
|
| ||
MADRS | Clinician/researcher |
|
|
|
|
| ||
Health status and quality of life | CGI | Clinician/researcher |
|
|
|
|
| |
SF-12 | Patient |
|
|
|
|
| ||
EQ-5D | Patient |
|
|
|
|
| ||
Health economics | Resource usage | Patient |
|
|
| |||
Compliance and side effects | Morisky Questionnaire | Patient |
| |||||
UKUside effects scale | Clinician/researcher |
|
|
|
|
|
| |
